期刊文献+

人IL-18基因真核表达载体的构建

Construction of eukaryotic expression vector of human interleukin-18
下载PDF
导出
摘要 目的:通过克隆人的Interleukin-18基因,构建Interleukin-18基因的哺乳动物细胞真核表达载体。方法:把人基因组DNA通过PCR获得Interleukin-18,克隆载体pMD18-T/Interleukin-18,并将其转化到大肠杆菌里,最后进行重组真核表达载体pCDNA3.1/Interleukin-18的构建和鉴定。结果:以人总DNA为模板扩增出580 bp左右的特异性条带,测序结果与GeneBank测序结果相比,除两个碱基外,其余的完全一致,翻译成的氨基酸序列相同。对重组质粒pCDNA3.1/Interleukin-18进行双酶切鉴定并测序,结果也完全一致。结论:重组质粒pCDNA3.1/Interleukin-18由真核载体pCDNA3.1和Interleukin-18片段组成。且插入的Interleukin-18片段与已知序列完全相同。 Objective The eukaryotic expression vector of interleukin-18 was constructed according to the interleukin-18 gene of human.Method Interleukin-18 gene was obtained from human ge nome DNA by PCR.Vector pMD18-T/interleukin-18 was cloned and transformed into Escherichia coli,and the recombinant pCDNA3.1/interleukin-18 was constructe d and identified. Results The result showed that 580 bp specific fragment was amplified and identified.Sequencing result showed that the reading frame was not changed except one base compared with the GeneBank,and amino acid sequence was the same. Conclusion The result of i dentification and sequencing of pCDNA3.1 /interleukin-18 plasmid is the accordance with the expected length.
出处 《吉林医学》 CAS 2011年第22期4517-4519,共3页 Jilin Medical Journal
基金 吉林省科技发展计划项目[项目编号:200905176]
关键词 Interleukin-18基因 PCR 真核表达载体构建 Interleukin-18 PCR Construction of t he eukaryotic expression vector
  • 相关文献

参考文献7

二级参考文献18

  • 1Department of Hepatobiliary Surgery (Tang RF, Zhang FR, Peng L, Wang SX, Xiao Y and Zhang M),and Department of Dermatology (Wang SX), 4th Hospital, Hebei Medical University, Shijiazhuang 050011, China.Interleukin-1α, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):460-463. 被引量:6
  • 2Weller M. Predicting response to cancer chemotherapy: the role of P53 [J]. Cell Tissue Res, 1998, 292 (3): 435 - 445. 被引量:1
  • 3Agarwal ML, Taylor WR, Chernov MV, et al. The P53 network [J]. J Biol Chem, 1998, 273 (1): 1-4. 被引量:1
  • 4Joseph B, Lewensohn R, Zhivotovsky B. Role of apoptosis in the response of lung carcinomas to ant-cancer treatment [J].Ann N Y Acad Sci, 2000, 926:204 - 216. 被引量:1
  • 5Chang WT, Kang JJ, Lee KY, et al. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the P53pathway [J]. J Bio Chem, 2001, 276 (3): 2 221 - 2 227. 被引量:1
  • 6Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003, 102:3837-3844. 被引量:1
  • 7Kim DH, Yoo KH, Choi KS, et al. Gene expression profile of cytokine and growth factor during differentiation of bone marrowderived mesenchymal stem cell. Cytokine, 2005, 31 : 119-126. 被引量:1
  • 8Nakamura K, Ito Y, Kawano Y, et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther, 2004, 11:1155-1164. 被引量:1
  • 9Sato H, Kuwashima N, Sakaida T,et al. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors. Cancer Gene Ther, 2005, 12:757-768. 被引量:1
  • 10Nakamizo A, Marini F, Amano T,et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res, 2005, 8:3307-3318. 被引量:1

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部